A bio-engineered blood vessel designed for kidney dialysis patients showed promise in facilitating blood flow in early trial results. The vessel graft is billed as the first off-the-shelf product of its kind that incorporates human tissue and could help cut high dialysis costs related to vein access issues.

Full Story:

Related Summaries